Інфекційні хвороби,
Journal Year:
2024,
Volume and Issue:
3, P. 28 - 34
Published: Oct. 11, 2024
After
the
COVID-19
pandemic,
persistence
of
Long
COVID
symptoms
is
particular
concern,
which
significantly
affects
quality
life
and
ability
to
work.
The
aim
study
establish
peculiarities
clinical
epidemiological
data
in
patients
infected
with
SARS-CoV-2
depending
on
period
illness.
Patients
methods.
We
examined
108
divided
into
three
groups:
those
confirmed
COVID-19,
COVID,
practically
healthy
persons.
features
course
were
determined
based
analysis
medical
records
developed
questionnaire.
Results.
Women
predominated
among
subjects
(56
%)
an
average
age
41.44
years.
main
that
characterized
picture
generalized
weakness/fatigue
(94
%),
headache
(74
fever/body
aches
cough
71
%
(p<0.05).
In
group,
compared
(40
(29
(3
(9
less
common,
sleep
disorders
/
insomnia
(17
muscle
pain
(11
shortness
breath
runny
nose
sneezing
(6
loss
(worsening)
appetite
sore
throat
difficulty
concentrating
abdominal
Conclusions.
Reduced
access
healthcare
services
leads
delayed
hospitalization,
prolonged
treatment,
complications.
level
vaccination
does
not
affect
risk
COVID.
Clinical
signs
COVID:
weakness/fatigue,
anxiety,
mood
disturbance,
are
detected
one
third
cause
a
decrease
overall
life.
most
persistent
general
headache,
breath,
disorders/insomnia
persist
34-42
from
moment
confirmed.
SARS-CoV-2
is
the
Coronavirus
responsible
for
COVID-19
pandemic.
Even
though
we
are
no
more
in
a
pandemic
situation,
people
getting
infected
some
of
them
needing
hospitalization,
and
few
die.
Methods:
We
did
retrospective
study
including
445
patients
who
accessed
Emergency
Section
Policlinico
Umberto
I,
Rome,
Italy,
where
they
had
routine
blood
exams.
In
this
study,
concentrated
on
complete
count,
creatinine,
azotemia.
The
data
was
analyzed
using
ANOVA,
Spearman
correlation,
ROC
analysis.
They
were
divided
into
four
groups
based
their
outcome:
(1)
emergency
group
(patients
with
mild
forms
quickly
discharged);
(2)
hospital
ward
after
admission
to
section
hospitalized
ward);
(3)
intensive
care
unit
(ICU)
that
required
assistance);
(4)
deceased
fatal
outcome).
Results:
found
significant
changes
azotemia,
hematocrit,
mean
corpuscular
hemoglobin
concentration,
basophils,
monocytes,
red
cell
distribution
width,
hemoglobin,
numbers
by
ANOVA
according
outcomes,
particularly
group.
Also,
outcome
correlations
eosinophils,
lymphocyte,
neutrophil,
platelet,
number
width.
Conclusions:
This
discloses
an
association
between
“classical”
biomarkers
severity
outcomes
Omicron
patients.
Medicina,
Journal Year:
2024,
Volume and Issue:
60(7), P. 1072 - 1072
Published: June 29, 2024
:
This
retrospective
study
aimed
to
investigate
the
impact
of
COVID-19
pandemic
on
most
frequently
performed
elective
pediatric
surgical
procedures
and
number
hospitalizations
compare
it
pre-pandemic
post-pandemic
periods.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 11, 2024
The
COVID-19
pandemic,
caused
by
the
novel
coronavirus
SARS-CoV-2,
has
had
a
profound
impact
on
global
health.
Rapid
and
accurate
diagnostic
tools
are
crucial
for
effective
disease
control
management.
enzyme-linked
immunosorbent
assay
(ELISA)
emerged
as
reliable
widely
used
method
detecting
antibodies
in
patients,
which
develop
response
to
SARS-CoV-2
infection.
While
ELISA
technique
is
identifying
presence
of
thus
confirming
exposure
virus,
its
role
predicting
clinical
course
severity
limited.
primarily
confirms
prior
virus
or
vaccination
status,
but
it
does
not
directly
correlate
antibody
levels
with
progression
disease.
variability
outcomes
influenced
factors
such
viral
load,
patient
co-morbidities,
genetic
predispositions,
timing
immune
response.
diverse
applications
epidemiology,
assessment,
therapeutic
development.
It
determines
prevalence,
aids
surveillance,
evaluates
vaccine
effectiveness
protection
duration.
quantitatively
measures
levels,
providing
insights
into
treatment
efficacy.
Challenges
include
specialized
facilities
personnel,
cross-reactivity,
false
results.
Multiplex
assays
integration
other
diagnostics
future
directions.
In
summary,
an
essential
tool
diagnostics,
enabling
precise
assessment
contributing
strategies.
development
point-of-care
devices
that
integrate
technology
could
enable
rapid
accessible
testing
various
settings.
Additionally,
integrating
platforms
enhance
overall
capabilities
COVID-19.
Despite
challenges,
ongoing
advancements
technology,
approaches,
hold
promise
further
improving
management
Інфекційні хвороби,
Journal Year:
2024,
Volume and Issue:
3, P. 28 - 34
Published: Oct. 11, 2024
After
the
COVID-19
pandemic,
persistence
of
Long
COVID
symptoms
is
particular
concern,
which
significantly
affects
quality
life
and
ability
to
work.
The
aim
study
establish
peculiarities
clinical
epidemiological
data
in
patients
infected
with
SARS-CoV-2
depending
on
period
illness.
Patients
methods.
We
examined
108
divided
into
three
groups:
those
confirmed
COVID-19,
COVID,
practically
healthy
persons.
features
course
were
determined
based
analysis
medical
records
developed
questionnaire.
Results.
Women
predominated
among
subjects
(56
%)
an
average
age
41.44
years.
main
that
characterized
picture
generalized
weakness/fatigue
(94
%),
headache
(74
fever/body
aches
cough
71
%
(p<0.05).
In
group,
compared
(40
(29
(3
(9
less
common,
sleep
disorders
/
insomnia
(17
muscle
pain
(11
shortness
breath
runny
nose
sneezing
(6
loss
(worsening)
appetite
sore
throat
difficulty
concentrating
abdominal
Conclusions.
Reduced
access
healthcare
services
leads
delayed
hospitalization,
prolonged
treatment,
complications.
level
vaccination
does
not
affect
risk
COVID.
Clinical
signs
COVID:
weakness/fatigue,
anxiety,
mood
disturbance,
are
detected
one
third
cause
a
decrease
overall
life.
most
persistent
general
headache,
breath,
disorders/insomnia
persist
34-42
from
moment
confirmed.
